201 related articles for article (PubMed ID: 12800122)
1. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
Varpula M; Pulkki K; Karlsson S; Ruokonen E; Pettilä V;
Crit Care Med; 2007 May; 35(5):1277-83. PubMed ID: 17414731
[TBL] [Abstract][Full Text] [Related]
3. Elevated nucleosome levels in systemic inflammation and sepsis.
Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
[TBL] [Abstract][Full Text] [Related]
4. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome.
Strutz F; Heller G; Krasemann K; Krone B; Müller GA
Intensive Care Med; 1999 May; 25(5):435-44. PubMed ID: 10401935
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis.
Buttenschoen K; Berger D; Hiki N; Buttenschoen DC; Vasilescu C; Chikh-Torab F; Seidelmann M; Beger HG
Eur J Surg; 2000 Jun; 166(6):459-66. PubMed ID: 10890542
[TBL] [Abstract][Full Text] [Related]
6. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
Jochberger S; Dörler J; Luckner G; Mayr VD; Wenzel V; Ulmer H; Morgenthaler NG; Hasibeder WR; Dünser MW
Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of endotoxin and antiendotoxin antibodies in patients with multiple injuries: a prospective clinical study.
Buttenschoen K; Berger D; Hiki N; Strecker W; Seidelmann M; Beger HG
Eur J Surg; 1996 Nov; 162(11):853-60. PubMed ID: 8956953
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock.
McLean AS; Huang SJ; Hyams S; Poh G; Nalos M; Pandit R; Balik M; Tang B; Seppelt I
Crit Care Med; 2007 Apr; 35(4):1019-26. PubMed ID: 17334249
[TBL] [Abstract][Full Text] [Related]
10. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
Adamik B; Zimecki M; Właszczyk A; Kübler A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
[TBL] [Abstract][Full Text] [Related]
11. Antiendotoxin therapy in sepsis.
Colletti RC; Dew RB; Goulart AE
Crit Care Nurs Clin North Am; 1993 Jun; 5(2):345-54. PubMed ID: 8398040
[TBL] [Abstract][Full Text] [Related]
12. Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review.
Barclay GR
Prog Clin Biol Res; 1995; 392():263-72. PubMed ID: 8524931
[No Abstract] [Full Text] [Related]
13. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness.
Granja C; Dias C; Costa-Pereira A; Sarmento A
Crit Care; 2004 Apr; 8(2):R91-8. PubMed ID: 15025783
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
Nguyen DN; Spapen H; Su F; Schiettecatte J; Shi L; Hachimi-Idrissi S; Huyghens L
Crit Care Med; 2006 Jul; 34(7):1967-74. PubMed ID: 16607230
[TBL] [Abstract][Full Text] [Related]
15. Antiendotoxin therapies for septic shock.
Corriveau CC; Danner RL
Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
[TBL] [Abstract][Full Text] [Related]
16. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock.
Opal SM; Scannon PJ; Vincent JL; White M; Carroll SF; Palardy JE; Parejo NA; Pribble JP; Lemke JH
J Infect Dis; 1999 Nov; 180(5):1584-9. PubMed ID: 10515819
[TBL] [Abstract][Full Text] [Related]
18. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
19. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
[TBL] [Abstract][Full Text] [Related]
20. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
